Tuesday, May 5, 2026

North Korea’s 9th Party Congress: What New Nuclear Strategies Will Kim Jong Un Unveil?

Lee Jae Myung's administration faces challenges in diplomacy with North Korea's nuclear plans, US-South Korea talks, and Japan's assertive stance.

Revolutionary Immune Therapy for Colon Cancer: How MAFB Protein Manipulation Enhances Treatment Response

Korea University researchers have developed a new colorectal cancer treatment strategy by regulating tumor-associated macrophages to enhance immune response.

How North Korean Food Imports Could Signal a New Era in Inter-Korean Trade: Key Procedures Explained

South Korea's Ministry of Unification discusses regulations for importing North Korean food, signaling a potential trade revival.

Tag: glucagon

North KoreaKoreaKimMilitarySouth KoreaAImarketrelationsInternational

Metabia Begins Dosing First Patient in Phase 1 Part 3 Trial of Obesity Drug DA-1726

Metabia begins Phase 1 trial for DA-1726, a dual-action obesity treatment, aiming for safety and efficacy in weight loss by 2026.

DA-1726: The New Dual-Action Obesity Treatment Set to Transform Weight Loss in 2026

MetaVia's DA-1726 obesity treatment trial approved by U.S. IRB, focusing on dual-action GLP-1 and Glucagon receptors for weight loss.

Top News

- Our Sponsors Ad -

Follow us

Cars

Tech

future

health

© Copyright by News1. All Rights Reserved.